Clinigen to distribute Etopophos, Vepesid in Australia and NZ

Australia |  News | 0 Comment | 03 Sep, 2019

Clinigen Group plc, the global pharmaceutical and services company, and CHEPLAPHARM Arzneimittel GmbH (‘CHEPLAPHAR...Read more

THC Global Groups' Australalia's Facility Opened by Federal Minister for Health

Australia |  News | 0 Comment | 22 Aug, 2019

THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal...Read more

Hand held device for predicting heart failure based on saliva

Australia |  News | 0 Comment | 28 Aug, 2019

Nano-sensors on the tip of the diagnostic stick measure heart disease biomarkers to accurately predict the risk of heart...Read more

Microba partners with Microbiome Research Centre to deliver world-class analysis

Australia |  News | 0 Comment | 27 Aug, 2019

Australia’s leading gut microbiome testing specialists Microba have partnered with the Microbiome Research Centre ...Read more

Australian scientists develop new vaccine for TB

Australia |  News | 0 Comment | 27 Aug, 2019

Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and...Read more

Evado is proud to announce the launch of Evado eConsent.

Australia |  News | 0 Comment | 22 Aug, 2019

eConsent App  The Evado eConsent App is targeted at any health related organisation that needs to record patient c...Read more

Australia's Propanc Biopharma gets US Patent

Australia |  News | 0 Comment | 23 Aug, 2019

Melbourne based Propanc Biopharma Inc., a biopharmaceutical company developing new cancer treatments for patients suffer...Read more

Q-Sera’s Blood Clotting Technology Granted Patent in US

Australia |  News | 0 Comment | 21 Aug, 2019

Australia based Medical device company Q-Sera Pty Ltd has announced that it has received a Notice of Allowance from the ...Read more

GE Healthcare partnership takes aim at Brain Aneurysms with AI

Australia |  News | 0 Comment | 13 Aug, 2019

GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging has announced a new research collab...Read more

The iQ Group Global stands among 5 most Innovative companies 2019

Australia |  News | 0 Comment | 12 Aug, 2019

The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top...Read more

ANDHealth joins leading institutes to drive digital healthcare

Australia |  News | 0 Comment | 09 Aug, 2019

Leading medical research institutes and universities in Western Australia have announced a new partnership with ANDHealt...Read more

Global Diagnostics Australia Incorporates AI into Radiology Applications

Australia |  News | 0 Comment | 08 Aug, 2019

Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has announced that it has adop...Read more

SpeeDx secures $15M from US investment partnership

Australia |  News | 0 Comment | 07 Aug, 2019

SpeeDx Pty. Ltd., an Australia based developer of disruptive new molecular diagnostic solutions has announced that it ha...Read more

TGA approves new drug for diabetes induced vision loss

Australia |  News | 0 Comment | 06 Aug, 2019

Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and...Read more

Chemist Warehouse to provide affordable orthodontic clear aligner therapy

Australia |  News | 1 Comment | 05 Aug, 2019

Chemist Warehouse, on 5 August 2019, announced its partnership with SmileDirectClub, the US-based&nb...Read more

Botanix receives commitments for A$40M in US-led institutional placement

Australia |  News | 0 Comment | 05 Aug, 2019

Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...Read more

Biocon, Mylan launch Ogivri in Australia

Australia |  News | 0 Comment | 02 Aug, 2019

Biocon Ltd. and Mylan N.V. have announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar...Read more

Alterity Therapeutics announces successful completion of Phase 1 Clinical Trial

Australia |  News | 0 Comment | 31 Jul, 2019

Alterity Therapeutics Limited has announced that it has successfully completed its Phase 1 study of PBT434, a novel, ora...Read more